Genome-wide functional synergy between amplified and mutated genes in human breast cancer.
about
JARID1B is a luminal lineage-driving oncogene in breast cancerIntegrated network analysis of transcriptomic and proteomic data in psoriasisCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesFrom integrative genomics to therapeutic targetsRecurrent epimutations activate gene body promoters in primary glioblastomaSystems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"Integrated analysis of transcriptomic and proteomic dataFunctional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes.Knowledge-based analysis of proteomics data.Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.PTK6 regulates IGF-1-induced anchorage-independent survival.Gene expression profiling of human breast tissue samples using SAGE-SeqAmplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.NRMT2 is an N-terminal monomethylase that primes for its homologue NRMT1.RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.Genomic DNA copy-number alterations of the let-7 family in human cancersManipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?Biomolecular events in cancer revealed by attractor metagenes.Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskDAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T CellsMolecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancerZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.FGFR1 is amplified during the progression of in situ to invasive breast carcinomaMolecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.Key signalling nodes in mammary gland development and cancer: Myc.Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer.Integrated genomic and epigenomic analysis of breast cancer brain metastasisInference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.Genetic and phenotypic diversity in breast tumor metastases.DNA amplifications in breast cancer: genotypic-phenotypic correlations.Quantitative knowledge-based analysis in compound safety assessment.Molecular biology of brain metastasis.Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.Emerging technologies for the genomic analysis of cancer.
P2860
Q24299326-A4BD2B7C-2CB8-4114-911F-B541C02B0B9EQ24610642-135B53B1-A99E-45DC-82A7-3C3100E9DD6BQ26743510-63D06B38-04AA-4538-B894-81843811173AQ26862726-F5D763EB-8D0A-4FDE-B1B7-DF76B98C27D9Q28385236-484613BE-F448-4BFF-90CE-C85FF390C91FQ28391909-866A2B1B-081C-4859-AF4B-44464BE06793Q28707991-1922532A-F5E9-42D0-B193-323528875DC5Q30496004-71C220D0-9D6D-46DB-9A54-96A5EC0EE406Q30578329-BA0F7BE1-BB74-422C-B90D-6576BFF447A2Q33604942-60531EC8-EE5A-44FC-B9EE-7C82A2167B03Q33644326-71673B06-A9EB-4E58-87B0-8A047097B823Q33736475-E78A9A34-357F-4E0B-90FF-38AA6332A905Q33754744-A3C7245B-FF6B-427C-8BB2-8D3C57DC6820Q33862729-3D304AF8-7D65-4BC8-BEE5-507CBCC42CE9Q34048144-8AF23631-1123-4C3A-84F0-0890F438E0D0Q34412371-2231101D-AE1E-40CD-B872-7611779C210BQ34417159-42A41A80-2D69-460F-BFAD-6CE39C64ACBEQ34611062-741A2B88-FAF0-4774-9475-37035CA3B590Q35158595-13A6CC9F-5973-4D6C-99E1-AFA684B9565FQ35161945-790C13EA-BF19-45F8-BA88-EAEDDBC58622Q35561120-573BBC15-4712-4D2F-A992-56E45878BA30Q35625533-A7F606CC-39BD-4CCA-B426-81897AC408A3Q35688107-F5E383E9-A250-4C0E-9587-A888A6A13B2EQ35740387-66A31AF0-B980-49B9-A8F3-834D4C86C3A8Q35889655-D3F42B7A-96F3-4B3C-B9D1-D0E08AD2B74AQ35898981-643EFA69-40D9-4EFD-B127-6B6E71EE3509Q36924421-80244F42-E2F2-482B-887F-263977B69404Q36988816-F1E2F730-D4FB-48C9-B55E-3BE54BE1268EQ37236899-CBB615DF-D966-492B-96D5-27B4D720FE69Q37467223-2E77B672-7C45-4B13-BC4B-DEB631D68507Q37472659-9BC981BE-1BA2-4221-AB53-CCF5E9A1A783Q37529191-B567555D-860F-466F-B427-CA5E26730358Q37592617-2D50090A-6685-4C55-B798-35D096463DF3Q37659374-6FFBD758-2C47-4B84-AB75-4354923958E7Q37763102-AEF923BB-E07A-4FCA-96C1-B4DB2A6B8E75Q37831322-89F084B0-B65E-4EBF-A6F0-5F132BFC2371Q38216231-DA9078B2-090A-465F-AD24-F050FB0E464BQ41280310-EF63EB86-95E5-4C8C-A77B-C99EC899C365Q41598833-D512937C-6D96-4306-9A48-639A82A26121Q41850318-E00E3651-1059-4136-ADAB-927DEB1EFFDD
P2860
Genome-wide functional synergy between amplified and mutated genes in human breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Genome-wide functional synergy ...... genes in human breast cancer.
@en
Genome-wide functional synergy ...... genes in human breast cancer.
@nl
type
label
Genome-wide functional synergy ...... genes in human breast cancer.
@en
Genome-wide functional synergy ...... genes in human breast cancer.
@nl
prefLabel
Genome-wide functional synergy ...... genes in human breast cancer.
@en
Genome-wide functional synergy ...... genes in human breast cancer.
@nl
P2093
P1433
P1476
Genome-wide functional synergy ...... genes in human breast cancer.
@en
P2093
Damir Dosymbekov
Evgeny Sviridov
Kornelia Polyak
Laura E Macconaill
Laura Mulvey
Tatiana Nikolskaya
Tatiana Serebryiskaya
Vadim Ustyansky
Valery Kaznacheev
P304
P356
10.1158/0008-5472.CAN-08-3082
P407
P577
2008-11-01T00:00:00Z